Hiltrud Brauch

38.3k citations

162 papers · 6.8k indexed · 1 hit paper · h-index 40

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism

Papers in

Cancer Research 57
- Cancer Genomics and Diagnostics 26
- Cancer, Hypoxia, and Metabolism 14
- Breast Cancer Treatment Studies 12
Pharmacology 29
- Pharmacogenetics and Drug Metabolism 28

Co-authors: Berton Zbar Matthias Schwab Péter Fritz M. Linehan Werner Schroth Michel Eichelbaum Gregor Weirich Christina Justenhoven
Journals: Cancer Research (18 papers)Nucleic Acids Research (14 papers)Breast Cancer Research and Treatment (11 papers)International Journal of Cancer (6 papers)Clinical Cancer Research (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Hiltrud Brauch

158 papers receiving 6.6k citations

Hit Papers

align trajectories log scale

Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma 1987 · 532 citations

Peers

Countries citing papers authored by Hiltrud Brauch

Since Specialization

Citations

This map shows the geographic impact of Hiltrud Brauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiltrud Brauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiltrud Brauch more than expected).

Fields of papers citing papers by Hiltrud Brauch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiltrud Brauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiltrud Brauch. The network helps show where Hiltrud Brauch may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiltrud Brauch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiltrud Brauch Line = papers co-authored together Hiltrud Brauch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial Clinical Cancer Research ·Thomas E. Mürdter, Werner Schroth, Matthew P. Goetz, Roman Tremmel, Svitlana Igel, Elke Schaeffeler, Simon Jäger, Sibylle Loibl, Andreas Gerteis, Lena Pfaff, Christina Bechtner, Denise Wrobel, Inger Marie Bernhoft, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthias Schwab, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Denise Wrobel, (unknown), Imma Fischer, Christoph Meisner, Michael Block, Hiltrud Brauch	2025	0
2	DNA methylation biomarkers for noninvasive detection of triple‐negative breast cancer using liquid biopsy International Journal of Cancer ·Mehdi Manoochehri, Nasim Borhani, Clarissa Gerhäuser, Yassen Assenov, Maximilian Schönung, Thomas Hielscher, Brock C. Christensen, Min Kyung Lee, Hermann‐Josef Gröne, Daniel B. Lipka, Thomas Brüning, Hiltrud Brauch, Yon‐Dschun Ko, Ute Hamann	2022	30
3	Obesity Alters Endoxifen Plasma Levels in Young Breast Cancer Patients: A Pharmacometric Simulation Approach Clinical Pharmacology & Therapeutics ·Anna Mueller‐Schoell, Lena Klopp‐Schulze, Werner Schroth, Thomas E. Mürdter, Robin Michelet, Hiltrud Brauch, Wilhelm Huisinga, Markus Joerger, Patrick Neven, Stijn L.W. Koolen, Ron H.J. Mathijssen, Ellen Copson, Diana Eccles, Sylvia Chen, Balram Chowbay, Arafat Tfayli, Nathalie K. Zgheib, Matthias Schwab, Charlotte Kloft	2020	21
4	Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer SHILAP Revista de lepidopterología ·Milène Volpato, Michele Cummings, Abeer M. Shaaban, Balkees Abderrahman, Mark A. Hull, Philipp Y. Maximov, Bradley M. Broom, Reiner Hoppe, Ping Fan, Hiltrud Brauch, V. Craig Jordan, Valerie Speirs	2020	6
5	The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer Clinical and Translational Science ·Jeanine Marie Nardin, Werner Schroth, Thais Abreu de Almeida, Thomas E. Mürdter, Solane Picolotto, Evelyn Castillo Lima Vendramini, Reiner Hoppe, Jenifer Primon Kogin, Diandra Miqueleto, Silvia Dark Robaskievicz de Moraes, Matthias Schwab, Roberto Pecoits‐Filho, Hiltrud Brauch, José Cláudio Casali da Rocha	2019	12
6	CYP2D6 Polymorphisms as Predictors of Outcome in Breast Cancer Patients Treated with Tamoxifen: Expanded Polymorphism Coverage Improves Risk Stratification Clinical Cancer Research ·Werner Schroth, Ute Hamann, Peter A. Fasching, Silke Dauser, Stefan Winter, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch	2010	66
7	Breast Cancer Risk Reduction and Membrane-Bound Catechol O -Methyltransferase Genetic Polymorphisms Cancer Research ·Yuan Ji, Janet E. Olson, Jianping Zhang, Michelle Hildebrandt, Liewei Wang, James N. Ingle, Zachary Fredericksen, Thomas A. Sellers, William H. Miller, J. Michael Dixon, Hiltrud Brauch, Michel Eichelbaum, Christina Justenhoven, Ute Hamann, Yon Ko, Thomas Brüning, Jenny Chang‐Claude, Shan Wang‐Gohrke, Daniel J. Schaid, Richard M. Weinshilboum	2008	36
8	Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes Journal of Clinical Oncology ·Werner Schroth, Lydia Antoniadou, Péter Fritz, Matthias Schwab, Thomas Muerdter, Ulrich M. Zanger, Wolfgang Simon, Michel Eichelbaum, Hiltrud Brauch	2007	336
9	A Novel Polymorphism in the Promoter Region of ERBB4 Is Associated with Breast and Colorectal Cancer Risk Clinical Cancer Research ·Matjaž Rokavec, Christina Justenhoven, Werner Schroth, Monica A. Istrate, Susanne Haas, Hans‐Peter Fischer, Caren Vollmert, Thomas Illig, Ute Hamann, Yon‐Dschun Ko, Damjan Glavač, Hiltrud Brauch	2007	23
10	Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas International Journal of Cancer ·Susanne Haas, Christiane Barbara Pierl, Volker Harth, Beate Pesch, Sylvia Rabstein, Thomas Brüning, Yon Ko, Ute Hamann, Christina Justenhoven, Hiltrud Brauch, Hans‐Peter Fischer	2006	56
11	Breast cancer risk is linked with ERCC2 genotypes and a corresponding haplotype in a German population Cancer Research ·Christina Justenhoven, Ute Hamann, Beate Pesch, Volker Harth, Sylvia Rabstein, Christian Baisch, Yon‐Dschun Ko, Thomas Brüning, Caren Vollmert, Thomas Illig, Hiltrud Brauch	2005	1
12	German populations with infrequent CHEK21100delC and minor associations with early-onset and familial breast cancer European Journal of Cancer* ·Muhammad Usman Rashid, Anna Jakubowska, Christina Justenhoven, Volker Harth, Beate Pesch, Christian Baisch, Christiane Barbara Pierl, Thomas Brüning, Yon Ko, Axel Benner, Heinz‐Erich Wichmann, Hiltrud Brauch, Ute Hamann	2005	27
13	p53 Alterations in thymic epithelial tumours Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Gregor Weirich, Paul M. Schneider, C. Fellbaum, Hiltrud Brauch, W. Nathrath, Matthew Scholz, H Präuer, Heinz Höfler	1997	20
14	Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in thevhlTumor Suppressor Gene or theretProtooncogene¹ The Journal of Clinical Endocrinology & Metabolism ·Hiltrud Brauch, Wolfgang Hoeppner, Hendrik Jähnig, Thorsten Wöhl, Dieter Engelhardt, F. Spelsberg, Michael M. Ritter	1997	59
15	Fixed archival tissue Molecular Biotechnology ·Gregor Weirich, Maria Anna Hornauer, Thomas Brüning, Heinz Höfler, Hiltrud Brauch	1997	23
16	Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe Human Genetics ·Damjan Glavač, Hartmut P.H. Neumann, Claudia Wittke, Hendrik Jaenig, O Masek, T Streicher, Friederike Pausch, Dieter Engelhardt, Karl H. Plate, Heinz Höfler, Fan Chen, Berton Zbar, Hiltrud Brauch	1996	79
17	Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation Human Genetics ·Hans-Jochen H. Decker, Christine Neuhaus, Anna Jauch, Michael R. Speicher, Thomas Ried, Michael Bujard, Hiltrud Brauch, S. Störkel, Michael Stöckle, Barbara Seliger, Christoph Huber	1996	13
18	Germline mutation screening and predictive testing in families with von Hippel-Lindau disease The American Journal of Human Genetics ·Hiltrud Brauch, Damjan Glavač, Friederike Pausch	1994	1
19	Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer Genes Chromosomes and Cancer ·Hiltrud Brauch, Kálmán Tory, Frederick Kotler, Adi F. Gazdar, Olive S. Pettengill, Bruce E. Johnson, Stephen L. Graziano, Tim Winton, Charles H.C.M. Buys, George D. Sorenson, Bernard J. Poiesz, J D Minna, B. Zbar	1990	83
20	Specific Genetic Change in Tumors Associated With von Hippel-Lindau Disease JNCI Journal of the National Cancer Institute ·K. Tory, Hiltrud Brauch, M. Linehan, Dominique Barba, Eric Oldfield, M. Katz, Bernd R. Seizinger, Yusuke Nakamura, R. White, Fray F. Marshall, M.I. Lerman, B. Zbar	1989	170

About Hiltrud Brauch

Hiltrud Brauch is a scholar working on Cancer Research, Pharmacology, Genetics, Oncology and Molecular Biology, having authored 162 papers that have together received 6.8k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (47 papers), Pharmacogenetics and Drug Metabolism (28 papers), Cancer Genomics and Diagnostics (26 papers), Cancer, Hypoxia, and Metabolism (14 papers), Epigenetics and DNA Methylation (12 papers), Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (11 papers) and Renal cell carcinoma treatment (11 papers). The work is most often cited by research in Cancer Research (2.4k citations), Pharmacology (966 citations), Oncology (2.3k citations), Genetics (1.7k citations) and Molecular Biology (3.4k citations). Hiltrud Brauch has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Berton Zbar, Matthias Schwab, Péter Fritz, M. Linehan, Werner Schroth, Michel Eichelbaum, Gregor Weirich, Christina Justenhoven, Benny K. Abraham and Thomas Brüning. Their work appears in journals such as Cancer Research, Nucleic Acids Research, Breast Cancer Research and Treatment, International Journal of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact